vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Magnera Corp (MAGN). Click either name above to swap in a different company.
Magnera Corp is the larger business by last-quarter revenue ($792.0M vs $617.8M, roughly 1.3× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -4.3%, a 7.6% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 12.8%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-13.0M). Over the past eight quarters, Magnera Corp's revenue compounded faster (54.9% CAGR vs 49.0%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
HIMS vs MAGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $792.0M |
| Net Profit | $20.6M | $-34.0M |
| Gross Margin | 71.9% | 12.2% |
| Operating Margin | 1.5% | 1.8% |
| Net Margin | 3.3% | -4.3% |
| Revenue YoY | 28.4% | 12.8% |
| Net Profit YoY | -20.8% | 43.3% |
| EPS (diluted) | $0.08 | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $792.0M | ||
| Q3 25 | $599.0M | — | ||
| Q2 25 | $544.8M | $839.0M | ||
| Q1 25 | $586.0M | $824.0M | ||
| Q4 24 | $481.1M | $702.0M | ||
| Q3 24 | $401.6M | $332.1M | ||
| Q2 24 | $315.6M | $556.0M | ||
| Q1 24 | $278.2M | $558.0M |
| Q4 25 | $20.6M | $-34.0M | ||
| Q3 25 | $15.8M | — | ||
| Q2 25 | $42.5M | $-18.0M | ||
| Q1 25 | $49.5M | $-41.0M | ||
| Q4 24 | $26.0M | $-60.0M | ||
| Q3 24 | $75.6M | $-15.2M | ||
| Q2 24 | $13.3M | $19.0M | ||
| Q1 24 | $11.1M | $14.0M |
| Q4 25 | 71.9% | 12.2% | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | 10.7% | ||
| Q1 25 | 73.5% | 10.7% | ||
| Q4 24 | 76.8% | 10.1% | ||
| Q3 24 | 79.2% | 10.7% | ||
| Q2 24 | 81.3% | 6.6% | ||
| Q1 24 | 82.4% | 6.2% |
| Q4 25 | 1.5% | 1.8% | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 4.9% | 1.5% | ||
| Q1 25 | 9.9% | 0.5% | ||
| Q4 24 | 3.9% | -3.1% | ||
| Q3 24 | 5.6% | 0.9% | ||
| Q2 24 | 3.5% | 3.1% | ||
| Q1 24 | 3.6% | 3.8% |
| Q4 25 | 3.3% | -4.3% | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 7.8% | -2.1% | ||
| Q1 25 | 8.4% | -5.0% | ||
| Q4 24 | 5.4% | -8.5% | ||
| Q3 24 | 18.8% | -4.6% | ||
| Q2 24 | 4.2% | 3.4% | ||
| Q1 24 | 4.0% | 2.5% |
| Q4 25 | $0.08 | $-0.95 | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $0.17 | $-0.51 | ||
| Q1 25 | $0.20 | $-1.15 | ||
| Q4 24 | $0.10 | $-1.69 | ||
| Q3 24 | $0.32 | $-0.33 | ||
| Q2 24 | $0.06 | $0.60 | ||
| Q1 24 | $0.05 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $264.0M |
| Total DebtLower is stronger | — | $1.9B |
| Stockholders' EquityBook value | $540.9M | $1.0B |
| Total Assets | $2.2B | $3.9B |
| Debt / EquityLower = less leverage | — | 1.86× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | $264.0M | ||
| Q3 25 | $345.8M | — | ||
| Q2 25 | $1.1B | $276.0M | ||
| Q1 25 | $273.7M | $282.0M | ||
| Q4 24 | $220.6M | $215.0M | ||
| Q3 24 | $165.5M | $230.0M | ||
| Q2 24 | $129.3M | $33.9M | ||
| Q1 24 | $105.2M | $30.2M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $877.4M | ||
| Q1 24 | — | $884.7M |
| Q4 25 | $540.9M | $1.0B | ||
| Q3 25 | $581.0M | — | ||
| Q2 25 | $562.7M | $1.1B | ||
| Q1 25 | $549.3M | $1.1B | ||
| Q4 24 | $476.7M | $1.1B | ||
| Q3 24 | $440.1M | $2.1B | ||
| Q2 24 | $362.0M | $2.4B | ||
| Q1 24 | $344.5M | $2.4B |
| Q4 25 | $2.2B | $3.9B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.9B | $4.1B | ||
| Q1 25 | $891.7M | $4.1B | ||
| Q4 24 | $707.5M | $4.0B | ||
| Q3 24 | $602.3M | $2.8B | ||
| Q2 24 | $480.5M | $1.5B | ||
| Q1 24 | $448.1M | $1.5B |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $2.0M |
| Free Cash FlowOCF − Capex | $-2.5M | $-13.0M |
| FCF MarginFCF / Revenue | -0.4% | -1.6% |
| Capex IntensityCapex / Revenue | 10.3% | 1.9% |
| Cash ConversionOCF / Net Profit | 2.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $2.0M | ||
| Q3 25 | $148.7M | — | ||
| Q2 25 | $-19.1M | $0 | ||
| Q1 25 | $109.1M | $65.0M | ||
| Q4 24 | $86.4M | $-58.0M | ||
| Q3 24 | $85.3M | $12.2M | ||
| Q2 24 | $53.6M | $38.0M | ||
| Q1 24 | $25.8M | $20.0M |
| Q4 25 | $-2.5M | $-13.0M | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $-69.5M | — | ||
| Q1 25 | $50.1M | $42.0M | ||
| Q4 24 | $59.5M | $-74.0M | ||
| Q3 24 | $79.4M | $3.6M | ||
| Q2 24 | $47.6M | $23.0M | ||
| Q1 24 | $11.8M | $12.5M |
| Q4 25 | -0.4% | -1.6% | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | 8.5% | 5.1% | ||
| Q4 24 | 12.4% | -10.5% | ||
| Q3 24 | 19.8% | 1.1% | ||
| Q2 24 | 15.1% | 4.1% | ||
| Q1 24 | 4.3% | 2.2% |
| Q4 25 | 10.3% | 1.9% | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 9.3% | 1.5% | ||
| Q1 25 | 10.1% | 2.8% | ||
| Q4 24 | 5.6% | 2.3% | ||
| Q3 24 | 1.5% | 2.6% | ||
| Q2 24 | 1.9% | 2.7% | ||
| Q1 24 | 5.0% | 1.3% |
| Q4 25 | 2.98× | — | ||
| Q3 25 | 9.43× | — | ||
| Q2 25 | -0.45× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 4.03× | 2.00× | ||
| Q1 24 | 2.32× | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
MAGN
| Other | $451.0M | 57% |
| United States And Canada | $341.0M | 43% |
